Beyond the Barrier: Targeted Radionuclide Therapy in Brain Tumors and Metastases
Brain tumors are notoriously difficult to treat. The blood-brain barrier provides a sanctuary site where residual and metastatic cancer cells can evade most therapeutic modalities. The delicate nature of the brain further complicates the decision of eliminating as much tumorous tissue as possible wh...
Saved in:
Main Authors: | Janik Puttemans (Author), Tony Lahoutte (Author), Matthias D'Huyvetter (Author), Nick Devoogdt (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2019-08-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Cutaneous Neuroendocrine Metastases of Visceral Origin Responsive to Surgical Resection and Targeted Radionuclide Therapy
by: Eleanor Tung-Hahn, et al.
Published: (2024) -
Peptide Receptor Radionuclide Therapy and Primary Brain Tumors: An Overview
by: Andrea Cimini, et al.
Published: (2021) -
Generic semi-automated radiofluorination strategy for single domain antibodies: [18F]FB-labelled single domain antibodies for PET imaging of fibroblast activation protein-α or folate receptor-α overexpression in cancer
by: Herlinde Dierick, et al.
Published: (2024) -
RADIONUCLIDE DIAGNOSTICS OF BONE METASTASES IN PATIENTS WITH PROSTATE CANCER
by: E. Portnyaga, et al.
Published: (2016) -
Optimizing the Safety and Efficacy of Bio-Radiopharmaceuticals for Cancer Therapy
by: Cyprine Neba Funeh, et al.
Published: (2023)